# TG Therapeutics Inc.

Canonical: https://abierto.us/vendors/tg-therapeutics-inc-jkpzkd19wmd7

- UEI: JKPZKD19WMD7
- CAGE: 8TBE4
- Location: Morrisville, NC
- Awards in window: 2 (12 transactions), $0 obligated, January 5, 2024 to September 2, 2026

## Awarding agencies

- Department of Veterans Affairs: 2 awards, $0

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: $0

## Competition

- Full and Open Competition: 2 awards

## Solicitations won

- Anti CD20 Antibodies (36E79724R0006), $186,776,520. https://abierto.us/opportunities/36e79724r0006

## Largest awards

- 36E79724D0024: $0, Nac Pharmaceuticals. New Award for Ublituximab-Xiiy 150mg/6ml Injection (Anti-Cd20 Antibodies with TG Therapeutics. Period of Performance June 17, 2024 - June 16, 2025 with Four ONE-YEAR Options.. https://www.usaspending.gov/award/CONT_IDV_36E79724D0024_3600/
- 36F79723D0120: $0, Nac Federal Supply Schedule. 65IB Administrative Correction: Maximum Order. https://www.usaspending.gov/award/CONT_IDV_36F79723D0120_3600/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/tg-therapeutics-inc-jkpzkd19wmd7.